Liver cancer is one of the fastest-growing cancers and a major contributor to cancer-related mortality. Minimally invasive, nonsurgical local liver therapies play a key role in appropriately selected patients with hepatobiliary cancer.
Magnetic resonance imaging (MRI) offers a compelling solution for liver interventions by providing multiplanar, real-time needle guidance without exposure to ionizing radiation.
It has excellent soft tissue contrast, outstanding spatial and temporal resolution, and functional imaging capabilities like diffusion-weighted imaging. Additionally, real-time temperature measurement during liver ablation helps to ensure complete tumor destruction while preserving surrounding healthy tissue and thus minimizing collateral damage
The integration of MRI guidance into hepatobiliary cancer diagnosis and treatment marks a significant advancement in interventional oncology. Its unique qualities enhance precise and safe planning, execution and monitoring of liver biopsies, liver tumor ablation, and percutaneous biliary drainage.
Shoutout and thank you to the coauthors: Marcel Gutberlet, Dominik Horstmann, Julian Glandorf, Bennet Hensen, Frank Wacker
Forschungscampus STIMULATE, Otto-von-Guericke Universität, Magdeburg, Germany / Department of Radiology, Hannover Medical School, Hannover, Germany
Interventional #MRI in the Liver: Why, When, and Where?
By Daniel Düx, MD; et al. ( @uni-magdeburg.de / Hannover Medical School, Germany).
🔗 marketing.webassets.siemens-healthineers.com/d67d220657dd...
#iMRI #interventionalRadiology #LiverBiopsy #MagnetomWorld #ImageGuidedTherapy #RadSky #MedSky